According to the 2021 third quarter report of Berry Gene, the company's main revenue was 1.112 billion yuan, up 2.27% year-on-year; the net profit attributable to the mother was 28.0449 million yuan, down 81.41% year-on-year; the deduction of non-net profit was 27.1816 million yuan, down 76.6% year-on-year; among them, in the third quarter of 2021, the company's single-quarter main revenue was 379 million yuan, up 3.17% year-on-year; the single-quarter net profit attributable to the mother was -3.1873 million yuan, down 109.55% year-on-year. Non-net profit in a single quarter - 3.1311 million yuan, down 112.24% year-on-year; debt ratio of 24.76%, investment income -39.1527 million yuan, financial expenses of 10.8087 million yuan, gross profit margin of 47.42%.
There are 1 new top ten circulating shareholders in the current period, Suzhou Qiming Chuangzhi Equity Investment Partnership (Limited Partnership) holds 3,653,187 shares, accounting for 1.23% of the outstanding shares; a total of 1 shareholder increases, Zhong Jiafu increases its holdings by 213,200 shares, and the shareholder holds 2.01% of the circulating shares; a total of 3 shareholders reduce their holdings, Hong Kong Securities Clearing Co., Ltd. reduces its holdings by 1,986,815 shares, the shareholder holds 6.11% of the outstanding shares, and Tianjin Junruiqi Equity Investment Partnership (Limited Partnership) 795,000 shares were reduced, and the shareholder's shareholding accounted for 5.96% of the outstanding shares, and the Industrial and Commercial Bank of China Co., Ltd. - Guangfa Science and Technology Power Equity Securities Investment Fund reduced its holdings by 570,900 shares, and the shareholder held 1.24% of the outstanding shares;
For a summary of the financial report data, please see the following figure:

This article is compiled by the Securities Star Data Center based on publicly available data and does not constitute investment opinions or suggestions, if there are any problems in the text, please contact us.